المؤلفون: Keith Tolley, Joanne Noble-Longster, Sam Mettam, Rachel Hibbs, Matthew Cawson, Luke Stainer, Tom Snell, Ari Manuel

المصدر: Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine. 18(9)

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Sleep Apnea, Obstructive, Neurology, Quality of Life, Humans, Neurology (clinical), Disorders of Excessive Somnolence, United Kingdom

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f547ba53809cf14353268a6a5b71cdca
https://pubmed.ncbi.nlm.nih.gov/35698455

المؤلفون: Sabrina Paganoni, Claire Watkins, Matthew Cawson, Suzanne Hendrix, Samuel P. Dickson, Newman Knowlton, Jamie Timmons, Machelle Manuel, Merit Cudkowicz

المصدر: Muscle & Nerve. 66:136-141

مصطلحات موضوعية: Cellular and Molecular Neuroscience, Cross-Over Studies, Double-Blind Method, Physiology, Physiology (medical), Amyotrophic Lateral Sclerosis, Humans, Neurology (clinical), Survival Analysis

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8402495de10bbf1526e35df603a7a91
https://doi.org/10.1002/mus.27569

المؤلفون: Ione Woollacott, George Morgan, Pratima Chowdary, Jamie O'Hara, Bethany Franks, Eline van Overbeeke, Nicola Dunn, Sissel Michelsen, Isabelle Huys, Antony Martin, Matthew Cawson, Jack Brownrigg, Ian Winburn, Jim Thomson

المصدر: Haemophilia : the official journal of the World Federation of Hemophilia.

مصطلحات موضوعية: Science & Technology, discrete choice experiment, gene therapies, haemophilia, Patient Preference, General Medicine, Genetic Therapy, Hematology, Hemophilia A, FRAMEWORK, Choice Behavior, United Kingdom, PHYSICIANS, PHARMACISTS PREFERENCES, Quality of Life, Humans, treatment attributes, HEALTH, INHIBITORS, Life Sciences & Biomedicine, Genetics (clinical), preferences, qualitative research

وصف الملف: Print-Electronic

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::881fb3fe69f345ce775efdae52a89b67
https://lirias.kuleuven.be/handle/20.500.12942/716389

المؤلفون: Carla Mamolo, Verna Welch, Roland B. Walter, Joseph C. Cappelleri, James Brockbank, Matthew Cawson, Chris Knight, Michele Wilson

المصدر: Springer, PharmacoEconomics. 39(1):121-131

الإتاحة: https://ideas.repec.org/a/spr/pharme/v39y2021i1d10.1007_s40273-020-00976-6.html

المؤلفون: Carla Mamolo, Joseph C. Cappelleri, Michele Wilson, Verna L Welch, Matthew Cawson, James Brockbank, Christopher Knight, Roland B. Walter

المصدر: Pharmacoeconomics

مصطلحات موضوعية: Adult, Budgets, Pediatrics, medicine.medical_specialty, Combination therapy, Gemtuzumab ozogamicin, Sialic Acid Binding Ig-like Lectin 3, CD33, Pharmacy, Drug Costs, 03 medical and health sciences, 0302 clinical medicine, Cost Savings, medicine, Humans, Original Research Article, 030212 general & internal medicine, Child, Pharmacology, Health economics, business.industry, 030503 health policy & services, Health Policy, Public Health, Environmental and Occupational Health, Myeloid leukemia, Induction chemotherapy, Gemtuzumab, Clinical trial, Leukemia, Myeloid, Acute, 0305 other medical science, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d31559c27a7f3f8e200fab2064e7e95f
https://doi.org/10.1007/s40273-020-00976-6

المؤلفون: Tyler W. Buckner, Jamie O'Hara, Brendan Mulhern, Eileen K. Sawyer, Michelle Witkop, Talaha M. Ali, Matthew Cawson, Mark W. Skinner, Diane J. Nugent, Brian O'Mahony, George Morgan, Nanxin Li, Michael Recht, Randall Curtis

المصدر: Haemophilia : the official journal of the World Federation of Hemophilia. 27(5)

مصطلحات موضوعية: Adult, Male, congenital, hereditary, and neonatal diseases and abnormalities, Pediatrics, medicine.medical_specialty, Activities of daily living, Haemophilia A, Hemorrhage, Haemophilia, Hemophilia A, Choice Behavior, hemic and lymphatic diseases, Surveys and Questionnaires, medicine, Humans, Haemophilia B, Genetics (clinical), Health policy, business.industry, Patient Preference, Hematology, General Medicine, Genetic Therapy, medicine.disease, Mental health, Health equity, Clinical trial, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0d700d8a8735fe8f22cdbe37e958658
https://pubmed.ncbi.nlm.nih.gov/34310811

المؤلفون: Elisabeth Hansson, Kerstin Hagberg, Matthew Cawson, T. H. Brodtkorb

المصدر: The Bone & Joint Journal. :527-534

مصطلحات موضوعية: Adult, Male, 030506 rehabilitation, medicine.medical_specialty, Percutaneous, Cost-Benefit Analysis, medicine.medical_treatment, Artificial Limbs, Trauma, Prosthesis, Amputation, Surgical, Osseointegration, Prosthesis Implantation, 03 medical and health sciences, 0302 clinical medicine, Outcome Assessment, Health Care, Humans, Medicine, Orthopedics and Sports Medicine, Femur, Prospective Studies, Transfemoral amputation, Sweden, 030222 orthopedics, business.industry, Middle Aged, Markov Chains, Surgery, Quality of Life, Prospective clinical study, Female, Quality-Adjusted Life Years, 0305 other medical science, business, Medical costs, Follow-Up Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1db1d5ae2ee980dcac2c9390ba075ca9
https://doi.org/10.1302/0301-620x.100b4.bjj-2017-0968.r1

المؤلفون: Lynda C. Doward, Sorrel Wolowacz, A Sinha, Matthew Cawson

المصدر: Value in Health. 22:S642

مصطلحات موضوعية: medicine.medical_specialty, Health utility, Conceptual design, business.industry, Health Policy, Public Health, Environmental and Occupational Health, Medicine, Cytomegalovirus disease, business, Intensive care medicine

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::01db1d2fa0fd23752613df60f4346d7f
https://doi.org/10.1016/j.jval.2019.09.1259

المؤلفون: Dean Spurden, Henry Wildey, Michelle Orme, Matthew Cawson, Stephen Mitchell, Christopher Knight, Alex Bird

المصدر: BASE-Bielefeld Academic Search Engine
BMC Musculoskeletal Disorders

مصطلحات موضوعية: Oncology, musculoskeletal diseases, medicine.medical_specialty, Cost-Benefit Analysis, Anti-Inflammatory Agents, Arthritis, Antibodies, Monoclonal, Humanized, Severity of Illness Index, Drug Costs, Receptors, Tumor Necrosis Factor, Etanercept, Psoriatic arthritis, Rheumatology, Internal medicine, Surveys and Questionnaires, medicine, Adalimumab, Humans, Orthopedics and Sports Medicine, skin and connective tissue diseases, Biological Products, business.industry, Tumor Necrosis Factor-alpha, Standard treatment, Arthritis, Psoriatic, Antibodies, Monoclonal, Bayes Theorem, medicine.disease, Infliximab, Golimumab, Models, Economic, Treatment Outcome, Immunoglobulin G, Immunology, Commentary, Quality-Adjusted Life Years, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed1a81297b2c3c6dc7119879d03dae45

المؤلفون: Brady RRW; Richard R. W. Brady, FRCSEd, MD, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Julia Scott, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Stephanie Grieveson, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Miriayi Aibibula, PhD, Coloplast Ltd, Peterborough, United Kingdom.; Matthew Cawson, MEnt, Coloplast Ltd, Peterborough, United Kingdom.; Tatjana Marks, MSc, Costello Medical Consulting Ltd, London, United Kingdom.; Jennifer Page, BSc, Costello Medical Consulting Ltd, Manchester, United Kingdom.; Audrey Artignan, MPhil, Costello Medical Consulting Ltd, Cambridge, United Kingdom.; Esben Bo Boisen, MSc, Coloplast A/S, Humlebaek, Denmark., Scott J; Richard R. W. Brady, FRCSEd, MD, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Julia Scott, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Stephanie Grieveson, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Miriayi Aibibula, PhD, Coloplast Ltd, Peterborough, United Kingdom.; Matthew Cawson, MEnt, Coloplast Ltd, Peterborough, United Kingdom.; Tatjana Marks, MSc, Costello Medical Consulting Ltd, London, United Kingdom.; Jennifer Page, BSc, Costello Medical Consulting Ltd, Manchester, United Kingdom.; Audrey Artignan, MPhil, Costello Medical Consulting Ltd, Cambridge, United Kingdom.; Esben Bo Boisen, MSc, Coloplast A/S, Humlebaek, Denmark., Grieveson S; Richard R. W. Brady, FRCSEd, MD, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Julia Scott, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Stephanie Grieveson, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Miriayi Aibibula, PhD, Coloplast Ltd, Peterborough, United Kingdom.; Matthew Cawson, MEnt, Coloplast Ltd, Peterborough, United Kingdom.; Tatjana Marks, MSc, Costello Medical Consulting Ltd, London, United Kingdom.; Jennifer Page, BSc, Costello Medical Consulting Ltd, Manchester, United Kingdom.; Audrey Artignan, MPhil, Costello Medical Consulting Ltd, Cambridge, United Kingdom.; Esben Bo Boisen, MSc, Coloplast A/S, Humlebaek, Denmark., Aibibula M; Richard R. W. Brady, FRCSEd, MD, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Julia Scott, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Stephanie Grieveson, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Miriayi Aibibula, PhD, Coloplast Ltd, Peterborough, United Kingdom.; Matthew Cawson, MEnt, Coloplast Ltd, Peterborough, United Kingdom.; Tatjana Marks, MSc, Costello Medical Consulting Ltd, London, United Kingdom.; Jennifer Page, BSc, Costello Medical Consulting Ltd, Manchester, United Kingdom.; Audrey Artignan, MPhil, Costello Medical Consulting Ltd, Cambridge, United Kingdom.; Esben Bo Boisen, MSc, Coloplast A/S, Humlebaek, Denmark., Cawson M; Richard R. W. Brady, FRCSEd, MD, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Julia Scott, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Stephanie Grieveson, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Miriayi Aibibula, PhD, Coloplast Ltd, Peterborough, United Kingdom.; Matthew Cawson, MEnt, Coloplast Ltd, Peterborough, United Kingdom.; Tatjana Marks, MSc, Costello Medical Consulting Ltd, London, United Kingdom.; Jennifer Page, BSc, Costello Medical Consulting Ltd, Manchester, United Kingdom.; Audrey Artignan, MPhil, Costello Medical Consulting Ltd, Cambridge, United Kingdom.; Esben Bo Boisen, MSc, Coloplast A/S, Humlebaek, Denmark., Marks T; Richard R. W. Brady, FRCSEd, MD, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Julia Scott, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Stephanie Grieveson, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Miriayi Aibibula, PhD, Coloplast Ltd, Peterborough, United Kingdom.; Matthew Cawson, MEnt, Coloplast Ltd, Peterborough, United Kingdom.; Tatjana Marks, MSc, Costello Medical Consulting Ltd, London, United Kingdom.; Jennifer Page, BSc, Costello Medical Consulting Ltd, Manchester, United Kingdom.; Audrey Artignan, MPhil, Costello Medical Consulting Ltd, Cambridge, United Kingdom.; Esben Bo Boisen, MSc, Coloplast A/S, Humlebaek, Denmark., Page J; Richard R. W. Brady, FRCSEd, MD, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Julia Scott, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Stephanie Grieveson, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Miriayi Aibibula, PhD, Coloplast Ltd, Peterborough, United Kingdom.; Matthew Cawson, MEnt, Coloplast Ltd, Peterborough, United Kingdom.; Tatjana Marks, MSc, Costello Medical Consulting Ltd, London, United Kingdom.; Jennifer Page, BSc, Costello Medical Consulting Ltd, Manchester, United Kingdom.; Audrey Artignan, MPhil, Costello Medical Consulting Ltd, Cambridge, United Kingdom.; Esben Bo Boisen, MSc, Coloplast A/S, Humlebaek, Denmark., Artignan A; Richard R. W. Brady, FRCSEd, MD, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Julia Scott, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Stephanie Grieveson, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Miriayi Aibibula, PhD, Coloplast Ltd, Peterborough, United Kingdom.; Matthew Cawson, MEnt, Coloplast Ltd, Peterborough, United Kingdom.; Tatjana Marks, MSc, Costello Medical Consulting Ltd, London, United Kingdom.; Jennifer Page, BSc, Costello Medical Consulting Ltd, Manchester, United Kingdom.; Audrey Artignan, MPhil, Costello Medical Consulting Ltd, Cambridge, United Kingdom.; Esben Bo Boisen, MSc, Coloplast A/S, Humlebaek, Denmark., Boisen EB; Richard R. W. Brady, FRCSEd, MD, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Julia Scott, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Stephanie Grieveson, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Miriayi Aibibula, PhD, Coloplast Ltd, Peterborough, United Kingdom.; Matthew Cawson, MEnt, Coloplast Ltd, Peterborough, United Kingdom.; Tatjana Marks, MSc, Costello Medical Consulting Ltd, London, United Kingdom.; Jennifer Page, BSc, Costello Medical Consulting Ltd, Manchester, United Kingdom.; Audrey Artignan, MPhil, Costello Medical Consulting Ltd, Cambridge, United Kingdom.; Esben Bo Boisen, MSc, Coloplast A/S, Humlebaek, Denmark.

المصدر: Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society [J Wound Ostomy Continence Nurs] 2023 Nov-Dec 01; Vol. 50 (6), pp. 475-483.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Mosby-Year Book Country of Publication: United States NLM ID: 9435679 Publication Model: Print Cited Medium: Internet ISSN: 1528-3976 (Electronic) Linking ISSN: 10715754 NLM ISO Abbreviation: J Wound Ostomy Continence Nurs

مواضيع طبية MeSH: Colostomy*/adverse effects , Ostomy*/adverse effects, Humans ; Ileostomy/adverse effects ; Retrospective Studies ; State Medicine ; Postoperative Complications/epidemiology ; Postoperative Complications/etiology ; Health Care Costs